A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union

Nutrition Journal

Volumn 14, Issue 1, 2015, Pages

  Glanville, Julie ^a   King, Sarah ^a   Guarner, Francisco ^b   Hill, Colin ^c   Sanders, Mary Ellen ^d  

^a UNIVERSITY OF YORK   (United Kingdom)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d DAIRY AND FOOD CULTURE TECHNOLOGIES   (United States)

Author keywords

EFSA; Health claims; Meta analysis; Probiotics; Regulatory; Systematic reviews

Indexed keywords

PROBIOTIC AGENT;

COHORT ANALYSIS; DATA ANALYSIS SOFTWARE; DATA EXTRACTION; EFFECT SIZE; ELECTRONIC SPREADSHEET; EUROPEAN UNION; EVIDENCE BASED MEDICINE; FOOD SAFETY; HEALTH FOOD; HUMAN; META ANALYSIS (TOPIC); METHODOLOGY; NUTRITIONAL ASSESSMENT; PRACTICE GUIDELINE; PUBLISHING; QUALITY CONTROL; REGISTER; RELIABILITY; RESEARCH PRIORITY; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW (TOPIC); FOOD; LEGISLATION AND JURISPRUDENCE; LITERATURE; NUTRITION POLICY; PROCEDURES;

EUROPEAN UNION; EVIDENCE-BASED MEDICINE; FOOD; HUMANS; META-ANALYSIS AS TOPIC; NUTRITION POLICY; PROBIOTICS; REVIEW LITERATURE AS TOPIC;

EID: 84928724733     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/s12937-015-0004-5     Document Type: Review

References (59)

1. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506-14.
2. Rowland I, Capurso L, Collins K, Cummings J, Delzenne N, Goulet O, et al. Current level of consensus on probiotic science-report of an expert meeting-London, 23 November 2009. Gut Microbes. 2010;1:436-9.
3. Guarner F, Sanders ME, Gibson G, Klaenhammer T, Cabana M, Scott K, et al. Probiotic and prebiotic claims in Europe: seeking a clear roadmap. Br J Nutr. 2011;106:1765-7.
4. Reid G. Opinion paper: Quo vadis - EFSA? Benef Microbes. 2011;2:177-81.
5. Katan MB. Why the European Food Safety Authority was right to reject health claims for probiotics. Benef Microbes. 2012;3:85-9.
6. Salminen S, Van Loveren H. Probiotics and prebiotics: health claim substantiation. Microb Ecol Health Dis 2012;23:10.3402/mehd.v23i0.18568.
7. Van Loveren H, Sanz Y, Salminen S. Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Food Sci Technol. 2012;3:247-61.
8. Binnendijk KH, Rijkers GT. What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics. Benef Microbes. 2013;4:223-30.
9. European Commission: Guidance on the implementation of Regulation no 1924/2006 on nutrition and health claims made on foods conclusions of the Standing Committee on the Food Chain and Animal Health. Brussels, 2007. [http://ec.europa.eu/food/food/labellingnutrition/claims/guidance-claim-14-12-07.pdf]
10. Food Safety Authority of Ireland. Probiotic Health Claims [http://www.fsai.ie/faqs/probiotic-health-claims.html]
11. National Food Agency of Sweden (Livsmedelsverkey). Vägledning till kontrollmyndigheter m.fl. Näringspåståenden och hälso-påståenden om livsmedel [http://www.slv. se/upload/dokument/livsmedelsforetag/vagledningar/vagledning-narings-och-halsopastaenden.pdf]
12. Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2015, Issue 2. Art. No.: CD006895. doi:10.1002/14651858. CD006895.pub3.
13. Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5: CD006095.
14. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307:1959-69.
15. Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One. 2012;7:e34938.
16. Al Faleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014, Issue 4. Art. No.: CD005496. doi: 10.1002/14651858. CD005496.pub4.
17. European Food Safety Authority. Guidance on the scientific requirements for health claims related to gut and immune function. EFSA J. 2011;9:1984.
18. Hungin AP, Mulligan C, Pot B, Whorwell P, Agreus L, Fracasso P, et al. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide. Aliment Pharmacol Ther. 2013;38:864-86.
19. Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol. 2012;46:468-81.
20. Piescik-Lech M, Shamir R, Guarino A, Szajewska H. Review article: the management of acute gastroenteritis in children. Aliment Pharmacol Ther. 2013;37:289-303.
21. Cochrane Collaboration. Evidence-based health care and systematic reviews [http://www.cochrane.org/about-us/evidence-based-health-care]
22. Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking reviews in health care. York: University of York; 2009.
23. European Food Safety Authority. Application of systematic review methodology to food and feed safety assessments to support decision making. EFSA J. 2010;8:1637.
24. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons Ltd; 2008.
25. Glasziou P, Irwig L, Bain C, Colditz G. Systematic Reviews in Health Care. Cambridge: Cambridge University Press; 2001.
26. Gough G, Oliver S, Thomas J. An Introduction to Systematic Reviews. London: SAGE Publications Ltd.; 2012.
27. Khan K, Zunz R, Kleijnen J, Antes G. Systematic Reviews to Support Evidence-based Medicine. London: Royal Society of Medicine Press; 2003.
28. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
29. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials. 1995;16:62-73.
30. National Health and Medical Research Council. How to review the evidence: systematic identification and review of the scientific literature. Canberra ACT: Natl Health Med Res Counc 1999. Available from: https://www.nhmrc. gov. au/-files-nhmrc/publications/attachments/cp65.pdf.
31. Buckley DI, Ansari M, Butler M, Williams C, Chang C. The Refinement of Topics for Systematic Reviews: Lessons and Recommendations from the Effective Health Care Program. Methods Research Report. (Prepared by Oregon Evidence-based Practice Center under Contract No. 290-2007-10057-I.), Agency for Healthcare Research and Quality Publication No 13-EHC023-EF. 2013.
32. Center for Reviews and Dissemination. PROSPERO International prospective register of systematic reviews. [http://www.crd.york.ac.uk/PROSPERO/]
33. Young T, Hopewell S. Methods for obtaining unpublished data. Cochrane Database Syst Rev 2011, Issue 11. Art. No.: MR000027. doi:10.1002/14651858. MR000027.pub2.
34. Agency for Healthcare Research and Quality. Systems to rate the strength of scientific evidence. Evidence Report/Technology Assessment: number 47. Rockville, MD: Agency for Healthcare Research and Quality; 2002.
35. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
36. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 2007;36:666-76.
37. Wells GA, Shea B, O'Connell B, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp]
38. Equator Network (online). Enhancing the quality and transparency of health research. [http://www.equator-network.org]
39. Greenhouse JB, Iyengar S. Sensitivity analysis and diagnostics. In: Cooper H, Hedges LV, editors. The handbook of research synthesis. New York, NY: Russell Sage Foundation; 1994. p. 383-98.
40. Van Hemert S, Meijerink M, Molenaar D, Bron PA, De Vos P, Kleerebezem M, et al. Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. BMC Microbiol. 2010;10:293.
41. Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, De Vincenzo A, et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ. 2007;335:340.
42. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541-51.
43. Deshpande GC, Rao SC, Keil AD, Patole SK. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med. 2011;9:92.
44. McFarland LV. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open. 2014;4:e005047.
45. Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther. 2011;33:1302-10.
46. Szajewska H, Wanke M, Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther. 2011;34:1079-87.
47. Szajewska H, Skorka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials. Aliment Pharmacol Ther. 2009;30:960-1.
48. Sung V, Cabana MD, D'Amico F, Deshpande G, Dupont C, Indrio F, et al. Lactobacillus reuteri DSM 17938 for managing infant colic: protocol for an individual participant data meta-analysis. BMJ Open. 2014;4:e006475.
49. Lee JH, O'Sullivan DJ. Genomic insights into bifidobacteria. Microbiol Mol Biol Rev. 2010;74:378-416.
50. Masco L, Huys G, De Brandt E, Temmerman R, Swings J. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol. 2005;102:221-30.
51. Barrangou R, Briczinski EP, Traeger LL, Loquasto JR, Richards M, Horvath P, et al. Comparison of the complete genome sequences of Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04. J Bacteriol. 2009;191:4144-51.
52. Collado MC, Moreno Y, Cobo JM, Hernandez M. Microbiological evaluation and molecular characterization of bifidobacteria strains in commercial fermented milks. Eur Food Res Technol. 2006;222:112-7.
53. EFSA Panel on Dietetic Products NaA. Scientific Opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006. EFSA J. 2010;8:1763.
54. European Food Safety Authority. Opinion of the Panel on dietetic products, nutrition and allergies (NDA) on a request from the Commission related to scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim. EFSA J. 2007;5:1-44.
55. Song F, Eastwood AJ, Gilbody S, Duley L, Sutton AJ. Publication and related biases. Health Technol Assess. 2000;4:1-115.
56. European Food Safety Authority. Tender specifications. OC/EFSA/SAS/2012/01 Scientific services to support EFSA systematic reviews. Parma: European Food Safety Authority; 2012.
57. European Food Safety Authority. General guidance for stakeholders on the evaluation of Article 13.1, 13.5 and 14 health claims. EFSA J. 2011;9:2135.
58. EFSA Panel on Dietetic Products NaAN. Scientific and technical guidance for the preparation and presentation of an application for authorisation of a health claim (revision 1). EFSA J. 2011;9:2170.
59. European Food Safety Authority. Scientific Opinion on the substantiation of a health claim related to increasing maternal folate status by supplemental folate intake and reduced risk of neural tube defects pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA J. 2013;11:3328.